JOSEPH SPARE: Open Payments
NPI 1548238298 · MARION, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,227 in 116 payments from 18 companies in 2025. Trend: 2023 $2,268 · 2024 $2,187 · 2025 $2,227
Food & beverage: $2,125Education: $101
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 14 | $283 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 10 | $266 |
| ABBVIE INC. | 18 | $261 |
| Janssen Pharmaceuticals, Inc | 12 | $255 |
| Teva Pharmaceuticals USA, Inc. | 10 | $248 |
| Alkermes, Inc. | 16 | $207 |
| Vanda Pharmaceuticals Inc. | 7 | $157 |
| Indivior Inc. | 4 | $104 |
| E.R. Squibb & Sons, L.L.C. | 5 | $85 |
| Supernus Pharmaceuticals, Inc. | 4 | $78 |
Products named: INGREZZA, CAPLYTA, VRAYLAR, ARISTADA, INVEGA SUSTENNA, FANAPT, SUBLOCADE, SPRAVATO.
Industry payments across OH — which companies pay providers there.
